NSCLC Clinical Trials

Completed

IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.

NCT01219348

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Center for Cancer ImmuneTherapy Herlev, Copenhagen, Denmark

Center for Cancer Immune Therapy, Dept. og Haematology/Oncology Copenhagen, Herlev, Copenhagen, Denmark

View Trial Details

Completed

Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC

NCT02175381

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Crete, Greece

"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece

401 Military Hospital of Athens Athens, Greece

Air Forces Military Hospital of Athens Athens, Greece Athens, Greece

View Trial Details

Completed

A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation

NCT00655161

Conditions: NSCLC
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

NCT00298415

Conditions: NSCLC
Locations: CH - Pneumologie Belfort, France

CHU Besancon - Pneumologie Besançon, France

CHU - Pneumologie Caen, France

CHU Grenoble, France

View Trial Details

Completed

Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)

NCT01368848

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III Salzburg, State of Salzburg, Austria

Univ.-Klinik für Innere Medizin V Innsbruck, Abteilung für Hämatologie und Onkologie Innsbruck, Tyrol, Austria

Landeskrankenhaus Feldkirch Feldkirch, Vorarlberg, Austria

View Trial Details

Completed

Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy

NCT00702975

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: University Lung Centre Nijmegen Dekkerswald Groesbeek, Gelderland, Netherlands

View Trial Details

Completed

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

NCT00297089

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Site Reference ID/Investigator# 3358 Fayetteville, Arkansas, United States

Site Reference ID/Investigator# 4102 Hot Springs, Arkansas, United States

Site Reference ID/Investigator# 2127 Greenbrae, California, United States

Site Reference ID/Investigator# 2417 Fort Collins, Colorado, United States

View all 48 locations

View Trial Details

Completed

Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

NCT00172380

Conditions: NSCLC
Locations: Department of Internal Medicine, National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

NCT00294736

Conditions: Lung Diseases, Lung Neoplasms, NSCLC, +5 more
Locations: Comprehensive Blood and Cancer Center Bakersfield, California, United States

Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

University of Edinburgh,Division of Oncology, Edinburgh, Scotland, United Kingdom

Aberdeen Royal Infirmary Aberdeen, United Kingdom

View Trial Details

Completed

Iressa as Second Line Therapy in Advanced NSCLC-Asia

NCT00478049

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Incheon, South Korea

Research Site Kyonggi-do, South Korea

Research Site Seoul, South Korea

Research Site Suwon, South Korea

View Trial Details

NSCLC

NSCLC trial results

Related conditions